Skip to content

Author

A. Divsalar

We have 1 of 250 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Bioactive nanomedicines for multidrug-resistant colorectal cancer: Actionable mechanisms, emerging particle classes, and translational barriers.

This review critically examines when nanomedicine can make such mechanistic activity pharmacologically and translationally meaningful in CRC and compares major nanomedicine design strategies, and assess nano-bio interactions, repeat-dose safety, manufacturing and clinical positioning.

Milad Rasouli, Fatemeh Babaei, Nadia Fallahhossein et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.